|Day's Range||0.009 - 0.009|
|52 Week Range||0.009 - 0.022|
|PE Ratio (TTM)||-1.80|
|Earnings Date||Mar 1, 2016 - Mar 5, 2016|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||0.25|
Genetic Technologies Limited , a molecular diagnostics company focused on cancer risk assessment, and provider of BREVAGenplus®, a first-in-class, clinically validated risk assessment test for sporadic ...
Genetic Technologies Limited , a molecular diagnostics company focused on cancer risk assessment, announced today an agreement with Dale Coyne Racing driver Ms. Pippa Mann to promote BREVAGenplus®, the ...
Genetic Technologies expects to raise more than $6 million through an offering of its American Depositary Shares.